ProCE Banner Activity

Targeting BCMA in Myeloma With CAR T-Cell Therapy

Clinical Thought
Natalie S. Callander, MD, examines the potential and the challenges of CAR T-cell therapy targeting BCMA in patients with multiple myeloma.

Released: September 22, 2020

Expiration: September 21, 2021

No longer available for credit.

Share

Faculty

Natalie S. Callander

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Celgene

Faculty Disclosure

Primary Author

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

Natalie S. Callander, MD, has disclosed that she has received funds for research support from Cellectar.